Cirrus Therapeutics is a startup based in the United States, 1 tracked investor.
Cirrus Therapeutics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Cirrus Therapeutics develops gene and cell therapies to treat dry age-related macular degeneration (AMD) by restoring immune regulation and replacing damaged retinal cells to prevent and reverse vision loss.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.